Literature DB >> 35978

Pharmacologic inhibition of preterm labor.

S N Caritis, D I Edelstone, E Mueller-Heubach.   

Abstract

Preterm labor is responsible for a majority of cases of perinatal morbidity and deaths. Prevention of preterm labor is not usually possible; thus pharmacologic treatment is the only recourse available. Numerous agents have been used to treat preterm labor, but none has proved to be superior. This report reviews the current information available about the pharmacology of labor-inhibiting drugs and discusses the clinical approach to the management of preterm labor.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 35978     DOI: 10.1016/0002-9378(79)90292-8

Source DB:  PubMed          Journal:  Am J Obstet Gynecol        ISSN: 0002-9378            Impact factor:   8.661


  8 in total

1.  Ritodrine-induced transient neutropenia in newborn twins after in utero exposure: report of first cases.

Authors:  Nurullah Okumus; Canan Türkyilmaz; E Esra Onal; Yildiz Atalay; Esin Koç; Tuncay Nas
Journal:  Br J Clin Pharmacol       Date:  2004-10       Impact factor: 4.335

2.  Obstetrics and Gynecology-Epitomes of Progress: The Use of beta-Sympathomimetic Drugs for the Inhibition of Premature Labor.

Authors:  B S Nuwayhid
Journal:  West J Med       Date:  1980-03

Review 3.  Progestin treatment for the prevention of preterm birth.

Authors:  Miha Lucovnik; Ruben J Kuon; Linda R Chambliss; William L Maner; Shao-Qing Shi; Leili Shi; James Balducci; Robert E Garfield
Journal:  Acta Obstet Gynecol Scand       Date:  2011-06-27       Impact factor: 3.636

Review 4.  Treatment of preterm labour. A review of the therapeutic options.

Authors:  S N Caritis
Journal:  Drugs       Date:  1983-09       Impact factor: 9.546

5.  Gestational age assessment by the lens examination method in normal and pathological pregnancies.

Authors:  E Z Zimmer; P Sujov; I Tchernin; B A Peretz
Journal:  Eur J Pediatr       Date:  1983-10       Impact factor: 3.183

Review 6.  A risk-benefit assessment of therapies for premature labour.

Authors:  K Higby; C R Suiter
Journal:  Drug Saf       Date:  1999-07       Impact factor: 5.606

7.  Cardiopulmonary effects of betamimetic tocolytic and glucocorticoid therapy in pregnant women.

Authors:  F Wolff; V Carstens; J H Fischer; D Behrenbeck; A Bolte
Journal:  Arch Gynecol       Date:  1986

8.  Effects of ritodrine, a beta 2-adrenoceptor agonist, on smooth muscle cells of the myometrium of pregnant rats.

Authors:  H Izumi; T Kishikawa
Journal:  Br J Pharmacol       Date:  1982-07       Impact factor: 8.739

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.